Evaluating the Effects of Snack Products on Energy

Exclusion Criteria

• •1. The subject has a current Axis I or Axis II comorbid psychiatric diagnosis or other symptomatic manifestations that, in the opinion of the examining physician (Investigator), will contraindicate treatment with caffeine.
• •2. Attention Deficit Disorder or Attention Deficit Hyperactivity Disorder
• •3. BMI ≤ 19 or ≥ 30 kg/m2.
• •4. The subject has documented allergies, adverse reactions, or intolerance to caffeine.
• •5. The subject has any significant medical illness or condition for which caffeine is contraindicated.
• •6. The subject has a history of drug dependence or substance use disorder based upon DSM-IV-TR criteria (excluding nicotine).
• •7. The subject has a positive urine drug or alcohol drug test result (to include nicotine).
• •8. The subject has participated in an investigational study or received an investigational drug within the past 28 days.
• •9. The subject has used nicotine products within 30 days of screening or during the duration of the study.
• •10. The subject is taking medications, that have CNS effects or affect performance, (such as sedating antihistamines and decongestant sympathomimetics, either oral or topical), and may interfere with efficacy or safety assessments.
• •11. The subject has a concurrent chronic or acute illness (such as allergic rhinitis or severe cold), disability, or other condition that might confound the results of rating tests administered in the study or that might increase risk to the subject. Similarly, the subject will be excluded if he or she has any additional conditions that, in the Investigator's opinion, would preclude the subject from completing the study or would not be in the best interest of the subject. This would include any significant illness or unstable medical condition that could lead to difficulty complying with the protocol.
• •12. The female subject is pregnant or lactating or planning on becoming pregnant during the study
• •13. Hypertension or other chronic medical conditions
• •14. Individuals who do not maintain a routine nighttime sleep schedule (e.g. no shift work).
• •15. Individuals judged by the Investigator to be unsuitable for enrollment in this study for any reason.
• •16. The subject has been diagnosed with phenylketonuria.
• •17. Inability to perform performance tests within the Normal range (i.e., performance no lower than 1SD below the mean) at screening.
• •18. The subject has a pre-existing medical condition.
• •19. Subject has been diagnosed with a sleeping disorder.
• •20. Subject has a fasting glucose of \>110 mg/dl.
• •21. Subject has an allergy to wheat, soy, nuts or other food.
• •22. Subject has Kosher or Halal dietary restrictions.
• •23. Subject reports never eating biscuits, cookies or crackers.
• •24. Epworth Sleepiness Scale ≥ at screening (i.e., evidence of excessive daytime sleepiness).
• •25. Dislike of chocolate flavorings